| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/18/2000 | US6015694 Method for stimulating an immune response utilizing recombinant alphavirus particles |
| 01/18/2000 | US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/18/2000 | US6015686 A eukaryotic promoter 5' of viral cdna which initiates within a cell the 5' to 3' synthesis of rna from complementary dna producing a vector construct which autonomously amplifies in a cell and expresses an heterologous sequence; gene therapy |
| 01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
| 01/18/2000 | US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog |
| 01/18/2000 | US6015671 Myocardial grafts and cellular compositions |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | US6015555 Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| 01/18/2000 | US6015554 Method of reconstituting human lymphoid and dendritic cells |
| 01/18/2000 | CA2132954C Modified ciliary neurotrophic factors |
| 01/16/2000 | CA2275511A1 A method for introducing a gene into a plant using a vector containing an adventitious bud redifferentiation gene as a selectable marker under the control of a light-inducible promoter |
| 01/13/2000 | WO2000001846A2 Characterisation of gene function using double stranded rna inhibition |
| 01/13/2000 | WO2000001835A2 Targeted integration into chromosomes using retroviral vectors |
| 01/13/2000 | WO2000001834A1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 01/13/2000 | WO2000001823A2 Flt3-l mutants and methods of use |
| 01/13/2000 | WO2000001821A2 Neurotransmission associated proteins |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001810A1 Novel promoter sequences of myostatin gene |
| 01/13/2000 | WO2000001807A1 Serine protease-specific monoclonal antibody and utilization thereof |
| 01/13/2000 | WO2000001805A1 Cells and animals deficient in protein kinase c epsilon |
| 01/13/2000 | WO2000001801A1 Ftsz multimeric proteins and their uses |
| 01/13/2000 | WO2000001731A1 Fused protein with direct bond of il-6-receptor to il-6 |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001716A2 Vasculoprotector |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001650A1 Method of vitamin production |
| 01/13/2000 | WO2000001394A1 Biocompatible and biodegradable compositions containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive apparatus |
| 01/13/2000 | WO2000001231A2 Improved methods for storing neural cells |
| 01/13/2000 | WO2000001221A2 Methods for interspecific hybridization |
| 01/13/2000 | WO1999060135A8 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 01/13/2000 | WO1999058688A3 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999055843A3 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects |
| 01/13/2000 | WO1999053060A3 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |
| 01/13/2000 | WO1999046286A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/13/2000 | DE19847422C1 Chinese hamster ovary cells, useful for large-scale production of recombinant proteins, especially enzymes |
| 01/13/2000 | DE19830141A1 Rekombinante Herpesviren für die Erzeugung rekombinanter Adeno-Assoziierter-Viren Recombinant herpes viruses for the production of recombinant adeno-associated virus |
| 01/13/2000 | CA2831321A1 Production of isoprenoid in recombinant yeast |
| 01/13/2000 | CA2789083A1 Characterisation of gene function using double stranded rna inhibition |
| 01/13/2000 | CA2337095A1 Method for genetic engineering of disease resistance using the drr206 class of proteins |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2332555A1 Novel promoter sequences of myostatin gene |
| 01/13/2000 | CA2332345A1 Flt3-l mutants and methods of use |
| 01/13/2000 | CA2332309A1 Neurotransmission associated proteins |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | CA2331343A1 Production of isoprenoid in recombinant yeast |
| 01/12/2000 | EP0971034A1 Process for preparing antibody molecules |
| 01/12/2000 | EP0971033A2 Test and model for Alzheimer's disease |
| 01/12/2000 | EP0970701A2 Pellets derived from keratinocytes for use as wound healing substances |
| 01/12/2000 | EP0970377A1 Diagnosis of epithelial cell abnormalities |
| 01/12/2000 | EP0970247A1 Detection of dna damaging agents |
| 01/12/2000 | EP0970231A1 Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance |
| 01/12/2000 | EP0970230A1 Improved sar plant transformation process |
| 01/12/2000 | EP0970228A1 Methods and means for gene silencing in transgenic plants |
| 01/12/2000 | EP0970223A1 Serine/threonine protein kinase |
| 01/12/2000 | EP0970221A1 Selection method for transgenic plants |
| 01/12/2000 | EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970211A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970201A1 Retroviral vectors capable of transducing non-dividing cells |
| 01/12/2000 | EP0970190A1 Isolated viable parasite intestinal cells |
| 01/12/2000 | EP0970189A1 In vitro model for hiv and other viral diseases |
| 01/12/2000 | EP0970187A1 Pituitary differentiation factor and methods of use thereof |
| 01/12/2000 | EP0970185A1 Insecticidal protein toxins from $i(photorhabdus) |
| 01/12/2000 | EP0970183A1 Micropathological patient replica based on unadulterated whole blood |
| 01/12/2000 | EP0970128A1 Immunotherapeutic ctla-4 binding peptides |
| 01/12/2000 | EP0970125A2 Histidine decarboxylase immunoreactivity to detect cancer |
| 01/12/2000 | EP0970122A1 Human anion channel |
| 01/12/2000 | EP0970119A1 Synaptic activation protein compositions and method |
| 01/12/2000 | EP0970116A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0969879A2 THE USE OF MONONUCLEAR PHAGOCYTES IN $i(IN VIVO) IMAGING OF HYPOXIC/ISCHAEMIC TISSUE |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0929661A4 Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics |
| 01/12/2000 | EP0846167A4 Nuclear-encoded transcription system in plastids of higher plants |
| 01/12/2000 | EP0666902B1 Assessment of bone cell activity |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/12/2000 | EP0572401B1 Viral particles having altered host range |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241216A Non-mammalian DNA virus having altered coat protein |